Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3014173rdf:typepubmed:Citationlld:pubmed
pubmed-article:3014173lifeskim:mentionsumls-concept:C0019682lld:lifeskim
pubmed-article:3014173lifeskim:mentionsumls-concept:C0014508lld:lifeskim
pubmed-article:3014173lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:3014173lifeskim:mentionsumls-concept:C0022877lld:lifeskim
pubmed-article:3014173lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:3014173lifeskim:mentionsumls-concept:C0086231lld:lifeskim
pubmed-article:3014173lifeskim:mentionsumls-concept:C0765250lld:lifeskim
pubmed-article:3014173pubmed:issue3lld:pubmed
pubmed-article:3014173pubmed:dateCreated1986-7-31lld:pubmed
pubmed-article:3014173pubmed:abstractTextThe enzyme immunoassays (EIAs) for antibody to human T-cell lymphotropic virus type III (HTLV-III) were rapidly adopted for screening donated blood and plasma. To evaluate the significance of a positive EIA reaction, test performance was examined in a blood bank screening program. Specimens were tested by EIA, Western blot assay, and HTLV-III/lymphadenopathy-associated virus (LAV) culture. The EIA was positive in 0.25% of 67 190 blood donations. Specimens were categorized and 57.3% had low (weak) reactivity, 12.7% had moderate reactivity, and 30.0% had high reactivity. Highly reactive specimens were strongly associated with a positive Western blot or culture (86.7%) in contrast to moderately and weakly reactive specimens (1.9%). Twenty-five of 29 donors interviewed with a highly reactive EIA had risk factors for HTLV-III/LAV infection. Risk factors were not identified for 74 of 75 interviewed donors with specimens of lower reactivity. The minimum calculated specificity was 99.82%. The use of the HTLV-III EIA has virtually eliminated the use of blood and plasma from HTLV-III/LAV infected donors.lld:pubmed
pubmed-article:3014173pubmed:languageenglld:pubmed
pubmed-article:3014173pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3014173pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3014173pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3014173pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3014173pubmed:statusMEDLINElld:pubmed
pubmed-article:3014173pubmed:monthJullld:pubmed
pubmed-article:3014173pubmed:issn0098-7484lld:pubmed
pubmed-article:3014173pubmed:authorpubmed-author:WardJ WJWlld:pubmed
pubmed-article:3014173pubmed:authorpubmed-author:AllenJ RJRlld:pubmed
pubmed-article:3014173pubmed:authorpubmed-author:FeorinoP MPMlld:pubmed
pubmed-article:3014173pubmed:authorpubmed-author:GrindonA JAJlld:pubmed
pubmed-article:3014173pubmed:authorpubmed-author:ParvinMMlld:pubmed
pubmed-article:3014173pubmed:authorpubmed-author:SchableCClld:pubmed
pubmed-article:3014173pubmed:issnTypePrintlld:pubmed
pubmed-article:3014173pubmed:day18lld:pubmed
pubmed-article:3014173pubmed:volume256lld:pubmed
pubmed-article:3014173pubmed:ownerNLMlld:pubmed
pubmed-article:3014173pubmed:authorsCompleteYlld:pubmed
pubmed-article:3014173pubmed:pagination357-61lld:pubmed
pubmed-article:3014173pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:3014173pubmed:meshHeadingpubmed-meshheading:3014173-...lld:pubmed
pubmed-article:3014173pubmed:meshHeadingpubmed-meshheading:3014173-...lld:pubmed
pubmed-article:3014173pubmed:meshHeadingpubmed-meshheading:3014173-...lld:pubmed
pubmed-article:3014173pubmed:meshHeadingpubmed-meshheading:3014173-...lld:pubmed
pubmed-article:3014173pubmed:meshHeadingpubmed-meshheading:3014173-...lld:pubmed
pubmed-article:3014173pubmed:meshHeadingpubmed-meshheading:3014173-...lld:pubmed
pubmed-article:3014173pubmed:meshHeadingpubmed-meshheading:3014173-...lld:pubmed
pubmed-article:3014173pubmed:meshHeadingpubmed-meshheading:3014173-...lld:pubmed
pubmed-article:3014173pubmed:meshHeadingpubmed-meshheading:3014173-...lld:pubmed
pubmed-article:3014173pubmed:meshHeadingpubmed-meshheading:3014173-...lld:pubmed
pubmed-article:3014173pubmed:meshHeadingpubmed-meshheading:3014173-...lld:pubmed
pubmed-article:3014173pubmed:meshHeadingpubmed-meshheading:3014173-...lld:pubmed
pubmed-article:3014173pubmed:meshHeadingpubmed-meshheading:3014173-...lld:pubmed
pubmed-article:3014173pubmed:meshHeadingpubmed-meshheading:3014173-...lld:pubmed
pubmed-article:3014173pubmed:year1986lld:pubmed
pubmed-article:3014173pubmed:articleTitleLaboratory and epidemiologic evaluation of an enzyme immunoassay for antibodies to HTLV-III.lld:pubmed
pubmed-article:3014173pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3014173lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3014173lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3014173lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3014173lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3014173lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3014173lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3014173lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3014173lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3014173lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3014173lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3014173lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3014173lld:pubmed